［1］Hussain M，Lu Y，Liu YQ，et al.Skp1：Implications in cancer and SCF-oriented anti-cancer drug discovery［J］.Pharmacol Res，2016，111：34-42.
［2］Zheng N，Zhou Q，Wang Z，et al.Recent advances in SCF ubiquitin ligase complex：Clinical implications［J］.Biochim Biophys Acta，2016，1866(1)：12-22.
［3］Zhang H，Kobayashi R，Galaktionov K，et al.p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase［J］.Cell，1995，82(6)：915-925.
［4］Hao Z，Huang S.E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy［J］.Front Biosci，2015，20：474-490.
［5］Zhang W，Cao L，Sun Z，et al.Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation［J］.Cell Cycle，2016，15(10)：1344-1351.
［6］Zhao H，Lu Z，Bauzon F，et al.p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer［J］.Oncogene，2016，175(10)：1-11.
［7］ChenY，He QY.Antitumor mechanism of Skp2 related senescence signaling pathway［J］.Progress in Physiological Sciences，2011，42(3)：221-222.［陈阳，何琪杨.Skp2相关衰老信号通路的抗肿瘤机制［J］.生理科学进展，2011，42(3)：221-222.］
［8］Chan CH，Lee SW，Wang J，et al.Regulation of Skp2 expression and activity and its role in cancer progression［J］.Scientific World Journal，2010，10：1001-1015.
［9］Lee Y，Lim HS.Skp2 Inhibitors：Novel anticancer strategies［J］.Curr Med Chem，2016，22(23)：2363-2379.
［10］Lin HK，Chen Z，Wang G，et al.Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence［J］.Nature，2010，464(7287)：374-379.
［11］Chan CH，Li CF，Yang WL，et al.The Skp2-SCF E3 ligase regulates akt ubiquitination，glycolysis，herceptin sensitivity and tumorigenesis［J］.Cell， 2012，149(5)：1098-1111.
［12］Chan CH，Morrow JK，Li CF，et al.Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression［J］.Cell，2013，154(3)：556-568.
［13］Inuzuka H，Gao D，Finley LW，et al.Acetylation-dependent regulation of Skp2 function［J］.Cell，2012，150(1)：179-193.
［14］Wei Z，Jiang X，Liu F，et al.Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo［J］.Tumor Biol，2013，34(1)：181-192.
［15］Wei Z，Jiang X，Qiao H，et al.STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells［J］.Cellular Signalling，2013，25(4)：931-938.
［16］Wang XC，Wu YP，Ye B，et al.Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma［J］.Molecular Cancer Research，2009，7(1)：12-22.
［17］Wang L，Ye X，Cai X，et al.Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells ［J］.Oncotarget，2015，6(20)：18027-18037.
［18］Gao JK，Wang LX，Long B，et al.Arsenic Trioxide inhibits cell growth and invasion via down-regulation of skp2 in pancreatic cancer cells［J］.Asian Pac J Cancer Prev，2015，16(9)：3805-3810.
［19］Tosco P，La Terra Maggiore GM，Forni P，et al.Correlation between Skp2 expression and nodal metastasis in Stage I and II oral squamous cell carcinomas［J］.Oral Diseases，2011，17(1)：102-108.
［20］Lin HK，Wang G，Chen Z，et al.Phosphorylation-dependent regulation cytosolic oncogenic function of Skp2 by Akt/PKB［J］.Nat Cell Biol，2009，11(4)：420-432.
［21］Gao D，Inuzuka H，Tseng A.Phosphorylation by Akt1 promotes skp2 cytoplasmic localization and impairs APC/Cdh1-mediated Skp2 destruction［J］.Nat Cell Biol，2009，11(4)：397-408.
［22］Li Z，Liang J，Wu WK，et al.Leptin activates RhoA/ROCK pathway to induce cytoskeleton remodeling in nucleus pulposus cells［J］.Int J Mol Sci，2014，15(1)：1176-1188.
［23］Chan CH，Lee SW，Li CF，et al.Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis［J］.Nature Cell Biology，2010，12(5)：457-466.
［24］Yamada S，Yanamoto S，Naruse T，et al.Skp2 regulates the expression of mmp-2 and mmp-9 and enhances the invasion potential of oral squamous cell carcinoma［J］.Pathol Oncol Res，2016，22(3)：625-632.
［25］Hung WC，Tseng WL，Shiea J，et al.Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells［J］.Cancer Lett，2010，288(2)：156-161.
［26］Nikesitch N，Tao C，Lai K，et al.Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response［J］.Blood Cancer J，2016，6：e432.
［27］Le-Trilling VT，Megger DA，Katschinski B，et al.Broad and potent antiviral activity of the NAE inhibitor MLN4924［J］.Sci Rep，2016，6：1-14.